Home
Curis Lifesciences Ltd EPS
Curis Lifesciences Ltd
NSE: Curis
EPS
Key Highlights
- The Earning per Share of Curis Lifesciences Ltd is ₹ 6.63 as of 26 Dec 25 .
- The Earning per Share of Curis Lifesciences Ltd is ₹ 24 as of Jun '24 .
Curis Lifesciences Ltd
NSE: Curis
EPS
Company Fundamentals for Curis Lifesciences Ltd
Market Cap
94 Cr
EPS
6.6
P/E Ratio (TTM)
17.6
P/B Ratio (TTM)
2.5
Day’s High
119.8
Day’s Low
115.0
DTE
2.4
ROE
0.0
52 Week High
147.9
52 Week Low
107.0
ROCE
0.0
Market Price of Curis Lifesciences Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
| Date | |
|---|---|
| 26 Dec 2025 | 117.1 |
| 24 Dec 2025 | 117 |
| 23 Dec 2025 | 120 |
| 22 Dec 2025 | 122.85 |
| 19 Dec 2025 | 115.1 |
| 18 Dec 2025 | 116 |
| 17 Dec 2025 | 119 |
| 16 Dec 2025 | 115.55 |
| 15 Dec 2025 | 118.2 |
| 12 Dec 2025 | 112 |
BlinkX Score for Curis Lifesciences Ltd
Asset Value vs Market Value of Curis Lifesciences Ltd
Market Value
₹ 95
Asset Value
Value addition
2.0 X
₹ 31
* All values are in ₹ crores
Competitive Comparison of EPS
| Company | Market Cap | EPS |
|---|
Curis Lifesciences Ltd | 94.59 | 6.63 |
Sun Pharmaceutical Industries Ltd | 412494 | 48.13 |
Divis Laboratories Ltd | 170514 | 93.61 |
Torrent Pharmaceuticals Ltd | 129044 | 64.02 |
Cipla Ltd | 121574 | 67.36 |
Dr Reddys Laboratories Ltd | 105919 | 69.16 |
| Company | |
|---|---|
| Curis Lifesciences Ltd | 94.59 |
| Sun Pharmaceutical Industries Ltd | 412494 |
| Divis Laboratories Ltd | 170514 |
| Torrent Pharmaceuticals Ltd | 129044 |
| Cipla Ltd | 121574 |
| Dr Reddys Laboratories Ltd | 105919 |
Historical Market Cap of Curis Lifesciences Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Curis Lifesciences Ltd
Historical Revenue of Curis Lifesciences Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Curis Lifesciences Ltd
Historical EBITDA of Curis Lifesciences Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Curis Lifesciences Ltd
Historical Net Profit of Curis Lifesciences Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Curis Lifesciences Ltd
Dividend Payout Over Time
Curis Lifesciences Ltd News Hub
Curis Lifesciences to declare Quarterly Result
Curis Lifesciences will hold a meeting of the Board of Directors of the Company on 4 December 2025.
Read more
29 Nov 25
NSE SME IPO of Curis Lifesciences subscribed 1.88 times
The initial public offer (IPO) of Curis Lifesciences received bids for 29,02,000 shares as against 1
Read more
07 Nov 25
NSE SME Curis Lifesciences prescribes gains on listing day
The stock listed at Rs 146.10, a 14.14% premium to the IPO price, and is currently down 1.44% over t
Read more
14 Nov 25
